Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice

BACKGROUND: Despite advances in surgery, radiotherapy, and chemotherapy, pancreatic adenocarcinoma often progresses rapidly and causes death. The physical decline of these patients is expected to impact their quality of life (QoL). Therefore, in addition to objective measures of effectiveness, the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Laquente, Berta, Macarulla, Teresa, Bugés, Cristina, Martín, Marta, García, Carlos, Pericay, Carles, Merino, Sandra, Visa, Laura, Martín, Teresa, Pedraza, Manuela, Carnero, Beatriz, Guardeño, Raquel, Verdaguer, Helena, Mut, Alejandro, Vilanova, David, García, Adelaida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350578/
https://www.ncbi.nlm.nih.gov/pubmed/32650765
http://dx.doi.org/10.1186/s12904-020-00610-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350578/
https://www.ncbi.nlm.nih.gov/pubmed/32650765
http://dx.doi.org/10.1186/s12904-020-00610-4

Ejemplares similares